Multiple Manufacturers

IMIPENEM-CILASTATIN SODIUM

Manufacturer:

Multiple Manufacturers

Imipenem-Cilastatin Sodium HCPCS:

J0743

HCPCS Code Descriptor:

Injection, cilastatin sodium; imipenem, per 250 mg

Category:

J Code

Imipenem-Cilastatin Sodium NDCs:

00006-3516-59, 63323-0322-25, 63323-0349-25, 63323-0322-93, 63323-0322-94, 44567-0705-10, 63323-0349-94, 63323-0349-93

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Imipenem-Cilastatin Sodium:

IMIPENEM-CILASTATIN SODIUM is an Antibiotic drug manufactured by Fresenius Kabi and administered via the Intravenous route of administration. The J Code: J0743 is aligned to the drug IMIPENEM-CILASTATIN SODIUM.

ACCESS PRICING AND MORE BY REGISTERING

J0743 Added Date:

January 1, 1993

J0743 Effective Date:

January 1, 1997

J0743 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Imipenem-Cilastatin Sodium billing and coding information.
Our team did not identify a source for Imipenem-Cilastatin Sodium patient assistance information. Please reach out to our team if you feel that this is a mistake.
IMIPENEM-CILASTATIN SODIUM prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for IMIPENEM-CILASTATIN SODIUM. Please check back in a few weeks.